Revvity, Inc.

RVTY · NYSE · USD

Financials

Annual

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Valuation and market statistics · USD millions unless noted · ratios on the twelve months ending at each period

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993	FY1992	FY1991	FY1990	FY1989	FY1988	FY1987	FY1986	FY1985
Valuation
Market cap	$10,969	$13,629	$13,490	$17,689	$23,356	$16,002	$10,761	$8,685	$8,120	$5,709	$6,027	$4,924	$4,628	$3,610	$2,260	$3,024	$2,394	$1,637	$3,094	$2,783	$3,046	$2,864	$2,152	$1,036	$3,662	$4,772	$1,903	$1,256	$948	$954	$1,250	$791	$1,035	$1,104	$1,384	$882	$1,005	$859	$922	$764	$1,027
Enterprise value	$13,566	$15,792	$15,952	$21,831	$27,913	$17,835	$12,826	$10,414	$9,924	$6,396	$6,802	$5,795	$5,388	$4,377	$3,062	$3,030	$2,772	$1,967	$3,407	$2,745	$2,788	$3,041	$2,510	$1,711	$4,248	$5,413	$2,273	$1,448	$1,051	$1,043	$1,294	$850	$1,060	$1,116	$1,380	$944	$1,090	$866	$971	$802	$1,088
P/E (TTM) at period end	45.48×	50.41×	19.46×	31.08×	24.76×	21.98×	47.29×	36.50×	27.75×	24.37×	28.37×	31.21×	27.68×	51.61×	295.17×	7.73×	29.16×	12.95×	23.28×	23.76×	37.26×	37.74×	40.64×	–	–	52.72×	67.00×	12.31×	28.14×	15.84×	23.02×	–	13.00×	12.58×	17.04×	11.92×	14.38×	12.50×	16.62×	17.01×	18.44×
P/S (TTM) at period end	3.84×	4.95×	4.90×	5.34×	6.10×	6.01×	3.73×	3.13×	3.60×	2.70×	2.86×	2.38×	2.15×	1.71×	1.18×	1.78×	1.54×	0.99×	1.73×	1.80×	2.07×	2.00×	1.40×	0.69×	2.75×	2.81×	1.40×	0.89×	0.65×	0.67×	0.88×	0.59×	0.38×	0.40×	0.51×	0.36×	0.61×	0.61×	0.75×	0.67×	0.89×
P/B at period end	1.51×	1.78×	1.71×	2.40×	3.27×	4.28×	3.82×	3.36×	3.24×	2.65×	2.86×	2.41×	2.32×	1.86×	1.23×	1.57×	1.47×	1.04×	1.96×	1.76×	1.85×	1.96×	1.60×	0.83×	2.69×	6.55×	3.45×	3.14×	2.89×	2.61×	3.41×	1.78×	2.17×	2.33×	3.29×	2.39×	2.88×	2.59×	3.40×	3.23×	5.05×
EV / EBITDA (TTM)	17.80×	20.39×	21.78×	18.66×	17.78×	16.68×	22.27×	20.64×	24.77×	16.21×	19.09×	21.04×	15.19×	19.18×	15.16×	12.28×	14.09×	8.74×	13.34×	12.42×	9.74×	14.23×	9.17×	7.80×	15.07×	19.92×	13.33×	18.05×	6.40×	8.11×	10.60×	5.06×	6.68×	6.99×	8.69×	6.86×	8.80×	–	–	–	–
EV / Sales (TTM)	4.75×	5.73×	5.80×	6.59×	7.29×	6.70×	4.45×	3.75×	4.40×	3.02×	3.23×	2.80×	2.50×	2.08×	1.60×	1.78×	1.79×	1.18×	1.91×	1.78×	1.89×	2.13×	1.64×	1.14×	3.19×	3.19×	1.67×	1.03×	0.72×	0.73×	0.91×	0.64×	0.39×	0.40×	0.51×	0.38×	0.66×	0.62×	0.79×	0.70×	0.94×
Returns
Return on equity	3.3%	3.5%	8.8%	7.7%	13.2%	19.5%	8.1%	9.2%	11.7%	10.9%	10.1%	7.7%	8.4%	3.6%	0.4%	20.3%	5.0%	8.1%	8.4%	7.4%	5.0%	5.2%	3.9%	(0.3%)	(0.0%)	12.4%	5.2%	25.5%	10.3%	16.5%	14.8%	(7.2%)	16.7%	18.5%	19.3%	20.0%	20.0%	20.7%	20.4%	19.0%	27.4%
Return on invested capital	3.2%	3.2%	2.7%	5.1%	7.9%	12.7%	7.1%	6.9%	3.6%	9.2%	7.9%	5.7%	8.3%	3.8%	0.1%	6.8%	4.2%	6.8%	8.2%	7.7%	11.6%	6.4%	7.3%	3.1%	–	8.0%	7.2%	3.5%	16.0%	13.1%	12.7%	26.0%	15.7%	18.4%	20.3%	17.2%	15.9%	20.4%	17.0%	9.2%	15.2%
Dividend yield	0.3%	0.3%	0.3%	0.2%	0.1%	0.2%	0.3%	0.4%	0.4%	0.5%	0.5%	0.6%	0.7%	0.9%	1.4%	1.1%	1.4%	2.0%	1.1%	1.3%	1.2%	1.2%	1.6%	3.4%	0.8%	0.6%	1.3%	2.0%	2.7%	2.8%	2.3%	3.9%	2.8%	2.5%	1.7%	2.5%	2.0%	–	–	–	–
Financial health
Current ratio	1.68×	3.60×	2.07×	2.13×	2.01×	1.36×	1.80×	1.60×	1.26×	1.97×	1.84×	1.79×	1.73×	1.67×	1.47×	2.11×	1.78×	1.61×	1.54×	1.56×	2.02×	1.68×	1.70×	1.42×	1.25×	1.43×	0.96×	1.10×	1.71×	1.75×	1.87×	1.71×	1.96×	2.05×	1.89×	1.58×	1.59×	2.10×	1.55×	1.63×	1.46×
Debt / equity	0.44×	0.41×	0.50×	0.60×	0.70×	0.53×	0.74×	0.73×	0.80×	0.49×	0.48×	0.51×	0.47×	0.48×	0.51×	0.22×	0.34×	0.32×	0.33×	0.10×	0.15×	0.26×	0.41×	0.64×	0.53×	1.05×	0.90×	0.72×	0.49×	0.37×	0.33×	0.28×	0.20×	0.17×	0.14×	0.26×	0.32×	0.15×	0.30×	0.25×	0.38×
Effective tax rate	10.6%	10.5%	1.9%	21.3%	26.1%	18.7%	4.0%	7.8%	47.1%	11.6%	9.6%	(5.1%)	(6.5%)	(29.2%)	98.2%	16.3%	26.7%	12.3%	11.5%	21.5%	0.2%	23.6%	32.0%	51.6%	101.8%	40.4%	36.7%	34.6%	43.3%	32.2%	36.9%	(87.7%)	34.7%	27.5%	32.5%	31.0%	30.0%	29.5%	31.5%	37.9%	37.1%
Share count
Diluted shares outstanding	117	123	125	126	117	112	112	112	111	110	113	114	114	115	114	118	117	119	121	126	131	130	129	126	108	102	91	92	91	95	106	112	113	113	111	114	116	119	111	108	107

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Income statement · USD millions

Line item	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993	FY1992	FY1991	FY1990	FY1989	FY1988	FY1987	FY1986	FY1985
Revenue and gross profit
Revenue	$2,912	$2,856	$2,755	$2,751	$3,312	$3,828	$2,663	$2,884	$2,778	$2,257	$2,116	$2,105	$2,070	$2,158	$2,105	$1,919	$1,702	$1,551	$1,660	$1,787	$1,546	$1,474	$1,429	$1,535	$1,505	$1,330	$1,695	$1,363	$1,408	$1,461	$1,427	$1,420	$1,333	$2,698	$2,789	$2,688	$2,474	$1,650	$1,406	$1,236	$1,145	$1,155
Cost of revenue	($1,311)	($1,292)	($1,217)	($1,211)	($1,322)	($1,394)	($933)	($1,488)	($1,437)	($709)	($665)	($696)	($708)	($784)	($763)	($687)	($946)	($852)	($926)	($1,072)	($923)	($859)	($846)	($906)	($904)	($722)	($918)	($787)	($991)	($1,040)	($1,008)	($1,013)	($958)	($2,305)	($2,387)	($2,306)	($2,141)	($1,346)	($1,114)	($984)	($935)	($928)
Gross profit	$1,601	$1,564	$1,538	$1,540	$1,990	$2,434	$1,730	$1,396	$1,341	$1,074	$1,013	$964	$1,005	$976	$963	$848	$761	$699	$734	$715	$623	$615	$583	$629	$601	$608	$777	$576	$417	$421	$420	$407	$375	$393	$402	$382	$334	$304	$292	$252	$210	$227
Operating expenses
Research and development	($216)	($216)	($197)	($217)	($222)	($200)	($146)	($189)	($194)	($139)	($124)	($113)	($108)	($132)	($132)	($116)	($95)	($90)	($93)	($110)	($98)	($87)	($82)	($83)	($86)	($81)	($86)	($71)	($46)	($45)	–	–	–	–	–	–	–	–	–	–	–	–
Selling, general and administrative	($1,026)	($992)	($994)	($1,023)	($1,026)	($975)	($716)	($815)	($812)	($626)	($590)	($587)	($648)	($582)	($627)	($624)	($487)	($477)	($486)	($431)	($374)	($365)	($362)	($386)	($431)	($411)	($419)	($327)	($226)	($243)	($291)	($285)	($278)	($235)	($242)	($223)	($196)	($180)	($169)	($151)	($133)	($130)
Total operating expenses	($1,242)	($1,208)	($1,191)	($1,239)	($1,247)	($1,176)	($863)	($1,034)	($1,017)	($778)	($719)	($713)	($840)	($748)	($860)	($757)	($604)	($583)	($586)	($540)	($472)	($453)	($445)	($445)	($478)	($411)	($593)	($471)	($385)	($299)	($332)	($324)	($244)	($272)	($278)	($257)	($226)	($205)	($194)	($173)	($169)	($163)
Total costs and expenses	($2,553)	($2,499)	($2,408)	($2,450)	($2,569)	($2,569)	($1,796)	($2,522)	($2,454)	($1,961)	($1,821)	($1,854)	($1,905)	($1,930)	($2,002)	($1,827)	($1,544)	($1,435)	($1,512)	($1,613)	($1,395)	($1,312)	($1,291)	($1,351)	($1,382)	($1,132)	($1,511)	($1,259)	($1,376)	($1,339)	($1,340)	($1,337)	($1,201)	($2,577)	($2,666)	($2,563)	($2,367)	($1,552)	($1,308)	($1,157)	($1,104)	($1,091)
Operating income	$359	$357	$347	$301	$743	$1,258	$867	$362	$324	$296	$295	$251	$165	$228	$103	$91	$158	$116	$148	$175	$152	$162	$138	$184	$123	$198	$184	$104	$32	$122	$88	$83	$131	$121	$123	$125	$108	$98	$98	$79	$41	$64
Earnings
EBITDA	$771	$762	$775	$732	$1,170	$1,570	$1,069	$576	$504	$401	$395	$356	$275	$355	$228	$202	$247	$197	$225	$255	$221	$286	$214	$274	$219	$282	$272	$170	$80	$164	$129	$122	$168	$159	$160	$159	$138	$124	–	–	–	–
Interest income	$24	$31	$73	$72	$4	$2	$1	$1	$1	$3	$1	$1	$1	$1	$1	$2	$1	$1	$4	$5	$9	$3	$2	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Interest expense	($94)	($92)	($96)	($99)	($104)	($55)	($50)	($64)	($67)	($44)	($42)	($38)	($36)	($50)	($46)	($25)	($16)	($16)	($82)	($42)	–	–	($48)	($105)	($280)	($128)	($75)	($7)	–	($65)	($9)	–	($122)	($12)	–	($1)	–	–	–	–	–	–
Pre-tax income	$261	$268	$316	$183	$652	$1,204	$906	$237	$258	$297	$244	$209	$124	$164	$55	$64	$166	$100	$104	$151	$151	$67	$99	$81	($9)	$34	$144	$45	$156	$54	$80	$86	($17)	$122	$121	$120	$107	$100	$97	$81	$72	$89
Income tax expense	($23)	($28)	($33)	($3)	($139)	($314)	($170)	($9)	($20)	($140)	($28)	($20)	$6	$11	$16	($63)	($27)	($27)	($13)	($17)	($32)	($0)	($23)	($26)	$4	($35)	($58)	($16)	($54)	($23)	($26)	($32)	($15)	($42)	($33)	($39)	($33)	($30)	($29)	($26)	($27)	($33)
Net income	$238	$241	$270	$693	$569	$943	$728	$228	$238	$293	$234	$212	$158	$167	$70	$8	$391	$82	$126	$133	$117	$82	$76	$53	($4)	($1)	$91	$28	$102	$34	$60	$54	($32)	$80	$88	$81	$74	$70	$69	$56	$45	$56
Per share
Diluted EPS (GAAP)	$2.10	$2.07	$2.20	$5.55	$4.50	$8.08	$6.49	$2.04	$2.13	$2.64	$2.12	$1.87	$1.39	$1.47	$0.61	$0.07	$3.31	$0.70	$1.07	$1.10	$0.926	$0.6234	$0.58	$0.41	($0.0329)	($0.0057)	$0.89	$0.31	$1.11	$0.37	$0.64	$0.51	($0.29)	$0.71	$0.78	$0.73	$0.65	$0.60	$0.57	$0.50	$0.42	$0.52
Basic EPS (GAAP)	$2.10	$2.07	$2.21	$5.56	$4.51	$8.12	$6.52	$2.06	$2.15	$2.67	$2.14	$1.89	$1.40	$1.49	$0.61	$0.07	$3.34	$0.71	$1.07	$1.12	$0.9357	$0.6324	$0.60	$0.42	($0.0329)	($0.0059)	$0.92	$0.31	$1.13	$0.37	$0.64	$0.53	($0.29)	$0.71	$0.78	$0.73	$0.65	$0.60	$0.57	$0.50	$0.42	$0.52
Basic shares outstanding	113	117	123	125	126	116	112	111	111	110	109	113	113	112	114	113	117	116	118	119	125	129	127	126	126	105	98	91	90	91	95	103	112	113	113	111	114	116	119	111	108	107
Margins
Gross margin	55.0%	54.8%	55.8%	56.0%	60.1%	63.6%	65.0%	48.4%	48.3%	47.6%	47.9%	45.8%	48.5%	45.2%	45.8%	44.2%	44.7%	45.1%	44.2%	40.0%	40.3%	41.7%	40.8%	41.0%	39.9%	45.7%	45.8%	42.2%	29.6%	28.8%	29.4%	28.7%	28.1%	14.6%	14.4%	14.2%	13.5%	18.4%	20.8%	20.4%	18.3%	19.7%
Operating margin	12.3%	12.5%	12.6%	10.9%	22.4%	32.9%	32.6%	12.6%	11.7%	13.1%	13.9%	11.9%	8.0%	10.6%	4.9%	4.7%	9.3%	7.5%	8.9%	9.8%	9.8%	11.0%	9.7%	12.0%	8.2%	14.9%	10.9%	7.7%	2.3%	8.3%	6.1%	5.8%	9.8%	4.5%	4.4%	4.7%	4.4%	6.0%	7.0%	6.4%	3.6%	5.5%
Net margin	8.2%	8.4%	9.8%	25.2%	17.2%	24.6%	27.3%	7.9%	8.6%	13.0%	11.1%	10.1%	7.6%	7.7%	3.3%	0.4%	23.0%	5.3%	7.6%	7.4%	7.6%	5.5%	5.3%	3.4%	(0.3%)	(0.0%)	5.3%	2.1%	7.2%	2.3%	4.2%	3.8%	(2.4%)	3.0%	3.1%	3.0%	3.0%	4.2%	4.9%	4.5%	3.9%	4.8%

Analyst consensus

Buy29 analysts

Bearish · 0 · Hold · 14 · Bullish · 15

Earnings history

	EPS	Estimate
Q3 2024	$1.28	$1.13	Beat
Q4 2024	$1.42	$1.37	Beat
Q1 2025	$1.01	$0.96	Beat
Q2 2025	$1.18	$1.14	Beat
Q3 2025	$1.18	$1.14	Beat
Q4 2025	$1.70	$1.57	Beat
Q1 2026	$1.06	$1.02	Beat
Q2 2026	$1.41	$1.21	Beat

Peers

Company overview

IPO dateJul 6, 1965

CEOPrahlad R. Singh

Employees11,000

SectorHealthcare

IndustryMedical - Diagnostics & Research

CountryUS

ExchangeNew York Stock Exchange

Websitewww.revvity.com

Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.